(7 years, 10 months ago)
Commons ChamberAs chair of the all-party group on rare, genetic and undiagnosed conditions, I know that the issue of clinical trials is a big one for patients, as they are concerned that exiting the EU will mean that nothing will replace those trials. Will my right hon. Friend assure the House and those patients that the trials will be replicated as soon as we leave the EU?
I can assure my hon. Friend that we are in extensive discussions with the biopharma industry on that particular issue, and those discussions will continue.